In the current research, we performed a comprehensive analysis for the expression and prognostic values of CBX family members in NSCLC and identified CBX3, which is the only member to function as an independent prognostic biomarker for LUAD. This evidence concerns the gene CBX3 and non-small cell lung carcinoma.